Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alpha 1-Antitrypsin Deficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06677307
What this trial is testing

A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110

Who this might be right for
Alpha-1 Anti-trypsin DeficiencyAATD
Korro Bio, Inc. 42
Early research (Phase 1)Study completedNCT01319331
What this trial is testing

The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes

Who this might be right for
DiabetesType 1 Diabetes
University of Colorado, Denver 12
Large-scale testing (Phase 3)Looking for participantsNCT07555483
What this trial is testing

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

Who this might be right for
Alpha 1 Antitrypsin Deficiency
Grifols Therapeutics LLC 40
Early research (Phase 1)Study completedNCT05579431
What this trial is testing

A Phase 1, First-in-human Study of VX-634

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Vertex Pharmaceuticals Incorporated 127
Testing effectiveness (Phase 2)Study completedNCT01684410
What this trial is testing

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Grifols Therapeutics LLC 30
Not applicableUnknownNCT03285100
What this trial is testing

The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation

Who this might be right for
Emphysema or COPDAneurysmCystic Fibrosis+1 more
Canisius-Wilhelmina Hospital 30
Not applicableStudy completedNCT01974830
What this trial is testing

AL1TER™: Alpha-1 Therapy, Evaluation, and Research Patient Registry

Who this might be right for
Alpha-1 Anti-trypsin Deficiency
Coram Clinical Trials 120
Not applicableStudy completedNCT04262284
What this trial is testing

Respreeza® Self-administration and Learning Program (AmAREtTI Study)

Who this might be right for
Alpha-1 Antitrypsin Deficiency
CSL Behring 15
Not applicableStudy completedNCT01810458
What this trial is testing

Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)

Who this might be right for
Liver FibrosisAlpha-1 Antitrypsin DeficiencyAAT Deficiency+1 more
University of Florida 109
Early research (Phase 1)Study completedNCT00242385
What this trial is testing

Pharmacokinetic Study of ARALAST (Human Alpha1- PI)

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Baxalta now part of Shire 25
Early research (Phase 1)Ended earlyNCT02363946
What this trial is testing

ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD)

Who this might be right for
Alpha-1 Antitrypsin Deficiency
Arrowhead Pharmaceuticals 65
Large-scale testing (Phase 3)Study completedNCT02282527
What this trial is testing

Assess Safety and PK of Liquid Alpha₁-Proteinase Inhibitor (Human) in Treating Alpha₁-Antitrypsin Deficiency

Who this might be right for
Alpha₁-Antitrypsin Deficiency
Grifols Therapeutics LLC 32
Large-scale testing (Phase 3)Ended earlyNCT02722304
What this trial is testing

Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAlpha1-antitrypsin Deficiency
Baxalta now part of Shire 7
Not applicableUnknownNCT04966221
What this trial is testing

Functional and Structural Lung Imaging in Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAlpha 1-Antitrypsin Deficiency
University of Nottingham 75
Not applicableStudy completedNCT02547532
What this trial is testing

Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency

Who this might be right for
Alpha-1 Antitrypsin Deficiency
Fondazione Salvatore Maugeri 100
Not applicableUnknownNCT03802357
What this trial is testing

Effects of Different Exercise Training Modalities in Alpha-1 Antitrypsin Deficiency Patients

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAlpha 1-Antitrypsin Deficiency
Schön Klinik Berchtesgadener Land 30
Testing effectiveness (Phase 2)Study completedNCT01054339
What this trial is testing

Safety & Efficacy Study of rAAV1-CB-hAAT for Alpha-1 Antitrypsin Deficiency

Who this might be right for
Alpha-1 Antitrypsin Deficiency
Beacon Therapeutics 9
Testing effectiveness (Phase 2)Study completedNCT00161707
What this trial is testing

Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency

Who this might be right for
Alpha1-antitrypsin Deficiency
Baxalta now part of Shire 40
Testing effectiveness (Phase 2)WithdrawnNCT06622668
What this trial is testing

NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease

Who this might be right for
Lung DiseasePulmonary DiseaseAATD+2 more
Intellia Therapeutics
Not applicableStudy completedNCT04799873
What this trial is testing

Alpha-1-Antitrypsin-Deficiency in COVID-19

Who this might be right for
Covid19
Universität des Saarlandes 10
Next Page